Log in to save to my catalogue

New Biomarkers to Predict the Evolution of In Situ Breast Cancers

New Biomarkers to Predict the Evolution of In Situ Breast Cancers

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4160633

New Biomarkers to Predict the Evolution of In Situ Breast Cancers

About this item

Full title

New Biomarkers to Predict the Evolution of In Situ Breast Cancers

Publisher

Cairo, Egypt: Hindawi Publishing Corporation

Journal title

BioMed research international, 2014-01, Vol.2014 (2014), p.1-7

Language

English

Formats

Publication information

Publisher

Cairo, Egypt: Hindawi Publishing Corporation

More information

Scope and Contents

Contents

Background. Genomic studies have shown that gene expression profiles are similar in in situ (CIS) and invasive breast cancers, suggesting that several biofunctional modifications of the transformation process occur before or during the development of CIS lesion. Methods. We investigated 3 biomarkers in 44 patients with CIS: TG2 (transglutaminase 2)...

Alternative Titles

Full title

New Biomarkers to Predict the Evolution of In Situ Breast Cancers

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4160633

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4160633

Other Identifiers

ISSN

2314-6133

E-ISSN

2314-6141

DOI

10.1155/2014/159765

How to access this item